Company overview
Basic information
Company name
Endorfinai, MB
Company code
307003429
Registered address
Vilnius, V. Nagevičiaus g. 3, LT-08237
Registration date
2024-10-01
Company age: 2 y.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Amusement and recreation activities n.e.c.
Ownership form
Private without foreign capital
MB Endorfinai
Company code: 307003429
Address: Vilnius, V. Nagevičiaus g. 3, LT-08237
Description
This description was generated by artificial intelligence.
Endorfinai, MB (company code 307003429) is an operational private small partnership registered on 1 October 2024. It is classified as a micro company in the national private non-financial companies sector and is organised under a CEO-only governance model. The company operates under private ownership, with more than 50% of the authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Its registered address is V. Nageviciaus g. 3, Vilnius, Vilniaus municipality, Vilnius County. The company’s main activity is classified under EVRK code S.93.29.00, amusement and recreation activities n.e.c.
Financially, the company reported revenue of EUR 6.5K in 2025, compared with a short 2024 period of 91 days that ended with a net loss of EUR 155. In 2025, profit before tax reached EUR 4.3K and net profit EUR 4.0K, corresponding to a profit margin of 61.4%. At the end of 2025, equity stood at EUR 3.9K, liabilities at EUR 3.6K, and total assets at EUR 7.4K. The earlier 2024 period showed negative equity of EUR 155 and liabilities of EUR 9.7K against total assets of EUR 9.5K.
Financially, the company reported revenue of EUR 6.5K in 2025, compared with a short 2024 period of 91 days that ended with a net loss of EUR 155. In 2025, profit before tax reached EUR 4.3K and net profit EUR 4.0K, corresponding to a profit margin of 61.4%. At the end of 2025, equity stood at EUR 3.9K, liabilities at EUR 3.6K, and total assets at EUR 7.4K. The earlier 2024 period showed negative equity of EUR 155 and liabilities of EUR 9.7K against total assets of EUR 9.5K.
Download a detailed company report
Make confident decisions with all the information about Endorfinai, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.